Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-03-10
DOI
10.1038/s41598-017-00143-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gr(i)p the ER to Stress Out Melanoma
- (2016) Wanping Xu et al. CANCER CELL
- Heat Shock Proteins Promote Cancer: It's a Protection Racket
- (2016) Stuart K. Calderwood et al. TRENDS IN BIOCHEMICAL SCIENCES
- Quantitative Proteomic Analysis of Histone Modifications
- (2015) He Huang et al. CHEMICAL REVIEWS
- Dynamics of chromatin accessibility and long-range interactions in response to glucocorticoid pulsing
- (2015) Diana A. Stavreva et al. GENOME RESEARCH
- Targeted therapies in bladder cancer: an overview of in vivo research
- (2015) Kim E. M. van Kessel et al. Nature Reviews Urology
- Comprehensive Catalog of Currently Documented Histone Modifications
- (2015) Yingming Zhao et al. Cold Spring Harbor Perspectives in Biology
- Targeting Signaling Transduction Pathways in Bladder Cancer
- (2015) Phillip H. Abbosh et al. Current Oncology Reports
- Chromatin structure and gene regulation: a dynamic view of enhancer function
- (2015) Diana A Stavreva et al. Nucleus
- Chromatin structure and gene regulation: a dynamic view of enhancer function
- (2015) Diana A Stavreva et al. Nucleus
- Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions
- (2014) Komal Jhaveri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies
- (2013) Jonathan W Goldman et al. BMC CANCER
- Stressing the Development of Small Molecules Targeting HSP90
- (2013) L. Neckers et al. CLINICAL CANCER RESEARCH
- Heat Shock Protein 90 (Hsp90) Selectively Regulates the Stability of KDM4B/JMJD2B Histone Demethylase
- (2013) Inbal Ipenberg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dynamic regulation of transcriptional states by chromatin and transcription factors
- (2013) Ty C. Voss et al. NATURE REVIEWS GENETICS
- Overlapping chromatin-remodeling systems collaborate genome wide at dynamic chromatin transitions
- (2013) Stephanie A Morris et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Manipulating the epigenome for the treatment of urological malignancies
- (2013) Colm J. O'Rourke et al. PHARMACOLOGY & THERAPEUTICS
- ER homeostasis and motility of NSCLC cell lines can be therapeutically targeted with combined Hsp90 and HDAC inhibitors
- (2013) Victoria Zismanov et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Expansion of the Lysine Acylation Landscape
- (2012) Christian A. Olsen ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Epigenomics of cancer – emerging new concepts
- (2012) Melanie R. Hassler et al. BIOCHIMIE
- Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non-Small Cell Lung Cancer
- (2012) T. Shimamura et al. CLINICAL CANCER RESEARCH
- The Therapeutic Target Hsp90 and Cancer Hallmarks
- (2012) Yoshihiko Miyata et al. CURRENT PHARMACEUTICAL DESIGN
- ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings
- (2012) Cora N. Sternberg et al. EUROPEAN UROLOGY
- New Therapeutic Challenges in Advanced Bladder Cancer
- (2012) Joaquim Bellmunt et al. SEMINARS IN ONCOLOGY
- Glycation and oxidation of histones H2B and H1: in vitro study and characterization by mass spectrometry
- (2011) Sofia Guedes et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers
- (2011) Paul G. Richardson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epigenetic biomarkers in urological tumors: A systematic review
- (2011) Carmen Jerónimo et al. CANCER LETTERS
- Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins
- (2011) Kyung-Hun Lee et al. CANCER SCIENCE
- The heat shock protein 90 inhibitor, AT13387, displays a long duration of action in vitro and in vivo in non-small cell lung cancer
- (2011) Brent Graham et al. CANCER SCIENCE
- Dynamic Exchange at Regulatory Elements during Chromatin Remodeling Underlies Assisted Loading Mechanism
- (2011) Ty C. Voss et al. CELL
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy
- (2009) R. Bao et al. CLINICAL CANCER RESEARCH
- Update on Hsp90 Inhibitors in Clinical Trial
- (2009) Y. Kim et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non-small cell lung cancer
- (2009) R. Bao et al. MOLECULAR CANCER THERAPEUTICS
- SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK
- (2008) Y. Okawa et al. BLOOD
- Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
- (2008) D. B. Solit et al. CLINICAL CANCER RESEARCH
- SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase Dependent Cancers
- (2008) S. Chandarlapaty et al. CLINICAL CANCER RESEARCH
- Hsp90 Affecting Chromatin Remodeling Might Explain Transgenerational Epigenetic Inheritance in Drosophila
- (2008) Douglas Ruden et al. CURRENT GENOMICS
- Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target
- (2008) Mariëlle I. Gallegos Ruiz et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started